DE1433681U - - Google Patents

Info

Publication number
DE1433681U
DE1433681U DENDAT1433681D DE1433681DU DE1433681U DE 1433681 U DE1433681 U DE 1433681U DE NDAT1433681 D DENDAT1433681 D DE NDAT1433681D DE 1433681D U DE1433681D U DE 1433681DU DE 1433681 U DE1433681 U DE 1433681U
Authority
DE
Germany
Prior art keywords
dwr
shah
dehe
ind
zwiweh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1433681D
Other languages
German (de)
English (en)
Publication of DE1433681U publication Critical patent/DE1433681U/de
Active legal-status Critical Current

Links

Landscapes

  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Polyamides (AREA)
  • Powder Metallurgy (AREA)
DENDAT1433681D Active DE1433681U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1433681U true DE1433681U (cg-RX-API-DMAC7.html)

Family

ID=742600

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1433681D Active DE1433681U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1433681U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
DE1433681U (cg-RX-API-DMAC7.html)
DE2043933B2 (de) N-(beta-naphthylaminomethyl)-aminocarbonsaeuren sowie diese enthaltende arzneimittel
Takeda et al. High-dose immunoglobulin G therapy for fulminant myocarditis
DE69426275T2 (de) Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum
SEIKI et al. A more extensive study on the uptake of labelled progesterone by the hypothalamus and pituitary gland of rats
EP0350738A2 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
Le Poncin-Lafitte et al. Age-associated changes in deoxyglucose uptake in whole brain
DE69010897T2 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
dosierte iv Immunglobulin-Therapie Methotrexat (MTX)
DE155632C (cg-RX-API-DMAC7.html)
DE1692944U (de) Kraftwagenspiegel.
DE1934014A1 (de) Aryloxyalkylguanidine sowie Verfahren zu deren Herstellung
DE1414330U (cg-RX-API-DMAC7.html)
DE16972C (de) Neuerungen an Tabakspfeifen und Cigarrenspitzen
EP0082266A1 (de) Substituierte 1,5-Diaminopentane, ihre Herstellung und diese enthaltende Arzneimittel
DE1618937A1 (de) Mittel gegen Viruserkrankungen
DE1745120U (de) Auf- und niederklappbarer ruhe- oder schlafsitz fuer kraftfahrer.
AT391134B (de) Verfahren zum herstellen von neuen glycinamidderivaten, deren additionssalzen und deren optischen isomeren
DE203910C (cg-RX-API-DMAC7.html)
DE1521050A1 (de) Verfahren zur Herstellung von Galvanoplastikteilen,insbesondere von Schallplattenpositiven oder -negativen
Cohort Federal Register/Vol. 78, No. 209/Tuesday, October 29, 2013/Notices
DE1430008U (cg-RX-API-DMAC7.html)
DE1379765U (cg-RX-API-DMAC7.html)
DE1361253U (cg-RX-API-DMAC7.html)
Schwarz et al. Expression of Cytokines and Co-stimulatory Molecules by Activated Human Microglia